Subscribe

Articles By Jim Kling

  • Scientists and the FMLA

    "Many women don't take advantage of it because they believe that the perception is, if they do, they're not, 'real scientists.' " --Sally Shaywitz

  • Careers in Biotech Manufacturing

    Biotech companies are gearing up to manufacture product, but they face a shortage of talent as most young scientists interested in biotechnology have congregated to research.

  • Pharmacogenomics Profiles

    There are molecular biologists, and biochemists, and immunologists. There are toxicologists, and pharmacologists. But there are no pharmacogenomicists.

  • Personalized Drugs, Personalized Careers

    "There isn't a pharmaceutical company that doesn't want these people. [Fellowship participants] are getting calls from headhunters 6 months or a year before they've finished." --Dave Flockhart, professor of medicine, Indiana University School of Medicine

  • Profile: The Scrutable and the Inscrutable

    "I gravitated toward the principle of minimum effort." --Ben Goertzel, chief scientific officer, BioMind LLC

  • The Mathematical Biology Job Market

    "If some significant fraction of the NIH budget is going to large-scale projects, and a substantial fraction of each project's budget goes into informatics, that translates into a lot of jobs." --David States, professor of bioinformatics, University of Washington

  • Two Careers in RNAi

    "Working with the close-knit group of scientists is giving her exposure to many aspects of the research, and that validates part of her reasoning for coming to a start-up company like Alnylam."

  • Hot Careers: RNAi

    "Although many of the jobs in the RNAi industry will closely resemble positions in other industries--biochemists, molecular biologists, and pharmacologists will be in demand--some specializations will be particularly sought after."

  • Life In Biotech

    "Here you have to make sure you're getting things done and meeting your objectives. It's almost a completely different experience."

  • Bully for Biotech

    Biotechnology is about opportunity. And risk.

Pages